Literature DB >> 8246966

Yin-yang 1 activates the c-myc promoter.

K J Riggs1, S Saleque, K K Wong, K T Merrell, J S Lee, Y Shi, K Calame.   

Abstract

Previous studies on the murine c-myc promoter demonstrated that a ubiquitously present protein, common factor 1 (CF1), bound at two sites located -260 and -390 bp from the P1 transcription start site. CF1 has been purified to near homogeneity and shown to be identical to the zinc finger protein Yin-yang 1 (YY1) as judged by similarity of molecular weight and other biochemical properties, immunological cross-reactivity, and the ability of recombinant YY1 to bind to CF1 sites. In cotransfection experiments, YY1 is a strong activator of transcription from c-myc promoter-based reporters. Furthermore, in murine erythroleukemia cells, overexpressed YY1 causes increased levels of c-myc mRNA initiated from both major transcription initiation sites of the endogenous c-myc gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246966      PMCID: PMC364820          DOI: 10.1128/mcb.13.12.7487-7495.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.

Authors:  A J van Zonneveld; S A Curriden; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  c-myc oncogene expression inhibits the initiation of myogenic differentiation.

Authors:  N Denis; S Blanc; M P Leibovitch; N Nicolaiew; F Dautry; M Raymondjean; J Kruh; A Kitzis
Journal:  Exp Cell Res       Date:  1987-09       Impact factor: 3.905

4.  Trans-activation of human MYC: the second promoter is target for the stimulation by adenovirus E1a proteins.

Authors:  M Lipp; R Schilling; G Bernhardt
Journal:  Oncogene       Date:  1989-05       Impact factor: 9.867

5.  In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer.

Authors:  B P Tsao; X F Wang; C L Peterson; K Calame
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

6.  A plasmacytoma-specific factor binds the c-myc promoter region.

Authors:  E Kakkis; K Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  Activation of skeletal alpha-actin gene transcription: the cooperative formation of serum response factor-binding complexes over positive cis-acting promoter serum response elements displaces a negative-acting nuclear factor enriched in replicating myoblasts and nonmyogenic cells.

Authors:  T C Lee; K L Chow; P Fang; R J Schwartz
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter.

Authors:  K Thalmeier; H Synovzik; R Mertz; E L Winnacker; M Lipp
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

9.  Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation.

Authors:  J Perez-Mutul; M Macchi; B Wasylyk
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

10.  Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene.

Authors:  H Karasuyama; N Tohyama; T Tada
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  76 in total

1.  The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.

Authors:  Juhong Liu; Fedor Kouzine; Zuqin Nie; Hye-Jung Chung; Zichrini Elisha-Feil; Achim Weber; Keji Zhao; David Levens
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

2.  Analysis of overrepresented motifs in human core promoters reveals dual regulatory roles of YY1.

Authors:  Hualin Xi; Yong Yu; Yutao Fu; Jonathan Foley; Anason Halees; Zhiping Weng
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

3.  High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster.

Authors:  S R Yant; W Zhu; D Millinoff; J L Slightom; M Goodman; D L Gumucio
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

4.  DNA binding sites for the transcriptional activator/repressor YY1.

Authors:  R P Hyde-DeRuyscher; E Jennings; T Shenk
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

5.  Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo.

Authors:  G A Michelotti; E F Michelotti; A Pullner; R C Duncan; D Eick; D Levens
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

6.  YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.

Authors:  E E Furlong; T Rein; F Martin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels.

Authors:  A Shrivastava; J Yu; S Artandi; K Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 8.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis.

Authors:  R U Jänicke; X Y Lin; F H Lee; A G Porter
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Influence of promoter potency on the transcriptional effects of YY1, SRF and Msx-1 in transient transfection analysis.

Authors:  T Lee; M E Bradley; J L Walowitz
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.